Histogen, a regenerative medicine company focused on stimulating the body’s stem cells to regenerate tissues and restore youthful function, has received approval of its Investigational New Drug (IND) application from

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In